Exemed is a regulatory-compliant, customer-centric, and global leading pharmaceutical company in India.
It was established in 2009 as part of a venture initiated by Mr. Pranav Patel. It is supported by two manufacturing facilities involved in the manufacturing of Drug-intermediates and specialty chemicals. Our state-of-the-art US FDA, EDQM, EU GMP certified facility is located in Luna and Vapi and headquartered in Vadodara, Gujarat.
Company Details
- Employees
- 394
- Founded
- -
- Address
- 1st Floor ,abs Tower, O.p Road -, Vadodara,gujarat 390007,india
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- easyvert.com.au
- Keywords
- Week Celebration 2025 🔥.
- HQ
- Vadodara, Gujarat
- Competitors
- Sudeep Pharma, Ami Lifesciences Pvt. Ltd., Oneiro Lifecare, Farmson Basic Drugs Private Limited, Innoxel Lifesciences Private Limited, Amoli Organics Limited, Apothecon Pharmaceuticals Pvt. Ltd., BDR Pharmaceuticals Int'l Pvt Ltd, Omgene Life Sciences Pvt. Ltd., Century Pharmaceuticals Limited.
Exemed Pharmaceuticals Questions
Exemed Pharmaceuticals's website is easyvert.com.au
Exemed Pharmaceuticals's LinkedIn profile is https://in.linkedin.com/company/exemed-pharmaceuticals
Exemed Pharmaceuticals has
394 employees.
View email and phone details for 394
employees at Exemed Pharmaceuticals.
Exemed Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Exemed Pharmaceuticals's top competitors are
Sudeep Pharma,
Ami Lifesciences Pvt. Ltd.,
Oneiro Lifecare,
Farmson Basic Drugs Private Limited,
Innoxel Lifesciences Private Limited,
Amoli Organics Limited,
Apothecon Pharmaceuticals Pvt. Ltd.,
Bdr Pharmaceuticals Int'l Pvt Ltd,
Omgene Life Sciences Pvt. Ltd.,
Century Pharmaceuticals Limited.
Exemed Pharmaceuticals's categories are Pharmaceutical Manufacturing
Exemed Pharmaceuticals's founding year is 2009
